ICU Medical's Neutron Needlefree Catheter Patency Device May Help Healthcare Facilities Deal With Cathflo(R) Shortages by Significantly Reducing Catheter Occlusions

摘要

2013 MAR 20 (VerticalNews) -- By a News Reporter-Staff News Editor at Journal of Engineering -- In thenwake of recently announced shortages in the availability of Cathflo(®) Activase(®), commonly used tonrestore patency in occluded catheters(1), ICU Medical, Inc. (NASDAQ: ICUI) said that its Neutronncatheter patency device may help clinicians deal with backorders of the drug by helping to reducencatheter occlusions by up to 50%(2), adding that in a recent trial of Neutron by a major East Coastnhospital, Cathflo usage was reduced by 74%.(3)